In 400 healthy adults in India, a 1-week intradermal IPC rabies regimen did not meet equivalence with the 1-month UTRC regimen: day 42 antibody GMR 0.59 (PCECV) and 0.76 (PVRV). All participants had titres ≥0.5 IU/mL from day 14 to 1 year; adverse events similar.
RCTn = 400
Thangaraj et al. Immunogenicity and safety of Institut Pasteur du Cambodge (IPC) and updated Thai Red Cross (UTRC) intradermal rabies vaccine regimens among healthy adults in India: A phase 4, open label, equivalence randomised controlled trial